What's new

PRAC-ETF considerations on the use of Ixchiq live attenuated virus vaccine against chikungunya

PRAC-ETF considerations on the use of Ixchiq live attenuated virus vaccine against chikungunya

May 2, 2025 - 17:24
 0
PRAC-ETF considerations on the use of Ixchiq live attenuated virus vaccine against chikungunya
Read More

Tags:

Previous Article

Emergency Task Force (ETF) documents

Next Article

Specsavers to launch Elton John eyewear collection

Related Posts

Human medicines European public assessment report (EPAR): Deferasirox Mylan, deferasirox, Date of authorisation: 26/09/2019, Revision: 11, Status: Authorised

Human medicines European public assessment report (EPAR...

May 2, 2025  0

Summary of opinion: Vyvgart, 25/04/2025 Positive

Summary of opinion: Vyvgart, 25/04/2025 Positive

Apr 25, 2025  0

Herbal medicinal product: Lupuli flos, Humulus lupulus L., C: ongoing call for scientific data

Herbal medicinal product: Lupuli flos, Humulus lupulus ...

Apr 30, 2025  0